These findings align with those of Xie et al. (34), who demonstrated in a co-culture model of lung cancer cells and activated Jurkat cells that lapatinib decreased PD-L1 expression, upregulated Cluster of Differentiation 69 levels, and enhanced IFN-γ secretion in Jurkat cells. Here, IFNG is linked to lung carcinoma.